A detailed history of Braidwell LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Braidwell LP holds 298,400 shares of BBIO stock, worth $8.68 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
298,400
Previous 345,571 13.65%
Holding current value
$8.68 Million
Previous $8.75 Billion 13.21%
% of portfolio
0.22%
Previous 0.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.91 - $31.3 $1.13 Million - $1.48 Million
-47,171 Reduced 13.65%
298,400 $7.6 Billion
Q2 2024

Aug 14, 2024

BUY
$23.0 - $31.04 $17,112 - $23,093
744 Added 0.22%
345,571 $8.75 Billion
Q1 2024

May 15, 2024

BUY
$27.35 - $40.45 $9.43 Million - $13.9 Million
344,827 New
344,827 $10.7 Billion

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.31B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.